C07C 279/16
Derivatives of guanidine, i.e. compounds containing the group [image cpc-sch-c07c-0970.gif], the singly-bound
Official title: having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
C07C279/16 (Derivatives of guanidine, i.e. compounds containing the group [image cpc-sch-c07c-0970.gif], the singly-bound) appears on 88 US grants and 56 published applications in this corpus.
Search patents in C07C- Granted patents
- 88
- Published applications
- 56
- Assignees
- 64
- Inventors
- 267
- Latest grant
- 15 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 16 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 1 |
| 2003 | 5 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 9 |
| 2012 | 0 | 4 |
| 2013 | 3 | 5 |
| 2014 | 5 | 6 |
| 2015 | 4 | 4 |
| 2016 | 5 | 3 |
| 2017 | 3 | 6 |
| 2018 | 6 | 5 |
| 2019 | 3 | 3 |
| 2020 | 2 | 2 |
| 2021 | 2 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Class A GPCR-binding compound modifier15 Apr 2025US 12,275,687 B2Riken
- Cycloheptylamine derivatives as anti-diabetic agents6 Feb 2024US 11,891,348 B2United Arab Emirates University
- Cycloheptylamine derivatives as anti-diabetic agents1 Aug 2023US 11,713,290 B2United Arab Emirates University
- Guanidine compounds and use thereof11 Oct 2022US 11,465,989 B2ImmunoMet Therapeutics Inc.
- Cycloheptylamine derivatives as anti-diabetic agents17 Aug 2021US 11,091,426 B1United Arab Emirates University
- Cellular energy compounds, compositions, and methods of use thereof25 May 2023US 2023/0159442 A1Vireo Systems, Inc.
- Cycloheptylamine derivatives as anti-diabetic agents18 Nov 2021US 2021/0355074 A1United Arab Emirates University
- Cycloheptylamine derivatives as anti-diabetic agents11 Nov 2021US 2021/0347725 A1United Arab Emirates University
- Class a gpcr-binding compound modifier25 Jun 2020US 2020/0199168 A1Riken
- Guanidine catalyst for curable compositions13 Feb 2020US 2020/0048189 A1Sika Technology AG
Most cited
By later US patents
- Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers47US 5,403,861 ACambridge NeuroScience, Inc. · 1995
- Method for treating hypertension with disubstituted granidine compounds45US 5,385,946 AState of Oregon, acting by and through the Oregon State Board of Higher Education, acting for and on behalf of the Oregon Health Sciences University and the University of Oregon · 1995
- Compounds for treating infectious diseases44US 5,840,893 AThe Picower Institute for Medical Research · 1998
- Substituted guanidines having high binding to the sigma receptor and the use thereof41US 5,312,840 AState of Oregon, acting by and through the Oregon State Board of Higher Education · 1994
- Process for the recovery of precious metal values from aqueous ammoniacal thiosulfate leach solutions34US 5,939,034 AHenkel Corporation · 1999